Darren R. Feldman, MD

Darren R. Feldman, MD

I am a board-certified medical oncologist specializing in the treatment of patients with genitourinary cancers. My primary expertise is in testicular cancer (a germ cell tumor) and kidney cancer (renal cell carcinoma). My research is focused on 1)developing new drugs or new drug combinations for testicular cancer and kidney cancer; 2) characterizing and preventing the long-term toxicities of treatment for testicular cancer (heart disease, metabolic syndrome, other cancers); and 3) identifying molecular features within germ cell tumors that predict sensitivity or resistance to chemotherapy and overall patient outcomes (in collaboration with the laboratory of Dr. Raju Chaganti).

I have presented my research and lectured at national and international meetings. I published a paper in the Journal of the American Medical Association, on the treatment of advanced testicular cancer and the associated short- and long-term toxicities. I was the recipient of the John Mendelsohn Housestaff Teaching Award for 2005-2006 for the Department of Medicine at Memorial Sloan Kettering Cancer Center.

Appointments for New Patients
Clinical Expertise

Genitoruinary malignancies with a focus on testicular cancer (germ cell tumors) and kidney cancer (renal cell carcinoma)

Languages Spoken

MD, University of Maryland School of Medicine


New York University School of Medicine


Memorial Sloan Kettering Cancer Center

Board Certifications

Internal Medicine; Medical Oncology

Publications by Darren R. Feldman
Visit PubMed for full listing of Darren R. Feldman journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.